Our Intellectual Property Litigation practice received this prestigious award for securing a number of successes over the past year “on all fronts across the spectrum of IP disputes and jurisdictions from coast to coast."
Arlene Chow, a first-chair Chambers-ranked litigator and trial lawyer, advises companies in the life sciences, pharmaceutical, and healthcare industries on a full spectrum of patent and intellectual property matters. She serves as Global Vice Chair of the firm’s Healthcare & Life Sciences Industry Group.
Ms. Chow advises pharmaceutical and biotech companies and medical device manufacturers on IP and patent litigation matters. Leveraging her background in biochemistry, she is able to frame matters from the perspective of a judge or jury in order to achieve the best solutions for her clients. Ms. Chow thrives on interaction with scientific experts, both in-house and externally, and adeptly simplifies highly technical information for her clients. She also performs patent due diligence in support of the purchase or sale of drugs or royalty streams.
Ms. Chow has particular experience with matters related to small molecule and biologic drugs for the treatment of a diverse assortment of medical indications. She also regularly advises clients on matters involving a wide variety of medical devices and dosage forms.
Ms. Chow is a United States Patent and Trademark Office (USPTO) registered patent attorney, and one of only a handful of lawyers who has been first-chair not only in district court trials and hearings, but also federal circuit arguments, and inter partes review hearings before the USPTO.
Ms. Chow serves as Co-Chair of the firm’s Women Enriching Business (WEB) committee in the New York office. She was shortlisted in the 2021 LMG Life Sciences Awards as “General Patent Litigator of the Year for New York.”
- Life Sciences Patent Network Conference, November 2022
- ACI Paragraph IV Disputes Master Symposium, September 2022
- Keynote Speaker, Women's Health Innovation Summit, September 2022
- Recently Filed ANDAs, Cases and PTAB Proceedings, Pharmaceutical Litigation Strategy Summit, September 2021